Literature DB >> 1385329

Effect of substance P and somatostatin on migration of polymorphonuclear (PMN) cells in vitro.

G Partsch1, M Matucci-Cerinic.   

Abstract

The effects of the two neuropeptides, substance P (SP) and somatostatin (SOM), on the migration of polymorphonuclear cells derived from 13 volunteers were investigated. The neuropeptides were applied in concentrations between 10(-12) and 10(-6) M. Only at a concentration of 10(-6) M SP did the chemotaxis of PMN cells increase slightly but statistically significantly. In contrast to SP, SOM showed a significant dose-dependent stimulation of chemotaxis, which was first traceable at 10(-10) M and increased up to 10(-6) M. Although it is uncertain whether in vivo SP and SOM contribute directly to the invasion of PMN cells into the joint cavity, the influence of these neuropeptides on PMN migration in vitro is a further indication of the neuropeptide involvement in the genesis of inflammation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385329     DOI: 10.1007/bf00918978

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  35 in total

1.  Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis, and psoriatic arthritis synovial fluid.

Authors:  S Marabini; M Matucci-Cerinic; P Geppetti; E Del Bianco; A Marchesoni; S Tosi; M Cagnoni; G Partsch
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts.

Authors:  D G Payan; C A Hess; E J Goetzl
Journal:  Cell Immunol       Date:  1984-04-01       Impact factor: 4.868

4.  In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P.

Authors:  C J Wiedermann; F J Wiedermann; A Apperl; G Kieselbach; G Konwalinka; H Braunsteiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

5.  Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation.

Authors:  A Perianin; R Snyderman; B Malfroy
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

6.  Collagenase synthesis of rheumatoid arthritis synoviocytes: dose-dependent stimulation by substance P and capsaicin.

Authors:  G Partsch; M Matucci-Cerinic; S Marabini; S Jantsch; A Pignone; M Cagnoni
Journal:  Scand J Rheumatol       Date:  1991       Impact factor: 3.641

7.  Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.

Authors:  C J Menkes; M Renoux; S Laoussadi; A Mauborgne; J Bruxelle; F Cesselin
Journal:  J Rheumatol       Date:  1993-04       Impact factor: 4.666

8.  Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis.

Authors:  J Larsson; A Ekblom; K Henriksson; T Lundeberg; E Theodorsson
Journal:  Scand J Rheumatol       Date:  1991       Impact factor: 3.641

9.  Somatostatin treatment of psoriatic arthritis.

Authors:  M Matucci-Cerinic; T Lotti; P Cappugi; V Boddi; L Fattorini; E Panconesi
Journal:  Int J Dermatol       Date:  1988 Jan-Feb       Impact factor: 2.736

10.  Gastrointestinal peptides in serum and synovial fluid from patients with inflammatory joint disease.

Authors:  I Lygren; M Ostensen; P G Burhol; G Husby
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

View more
  3 in total

1.  Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.

Authors:  Zsuzsanna Helyes; Erika Pintér; Katalin Sándor; Krisztián Elekes; Agnes Bánvölgyi; Dániel Keszthelyi; Eva Szoke; Dániel M Tóth; Zoltán Sándor; László Kereskai; Gábor Pozsgai; Jeremy P Allen; Piers C Emson; Adrienn Markovics; János Szolcsányi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

2.  Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae.

Authors:  S A Laws; A C Gough; A A Evans; M A Bains; J N Primrose
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Somatostatin does not attenuate intestinal injury in dextran sodium sulphate-induced subacute colitis.

Authors:  J D van Bergeijk; M E van Meeteren; C J Tak; A P van Dijk; M A Meijssen; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.